Tranexamic acid at cesarean delivery: drug-error deaths

Area of Science:

• Obstetrics and Gynecology
• Anesthesiology
• Patient Safety

Background:

• Tranexamic acid (TXA) is a critical intervention for managing postpartum hemorrhage (PPH).
• Its use is expanding globally, including during cesarean deliveries.
• However, inadvertent intrathecal administration of TXA has emerged as a serious safety concern.

Purpose of the Study:

• To highlight the increasing incidence of catastrophic errors involving intrathecal TXA administration.
• To emphasize the severe neurotoxicity and high mortality associated with this medication error.
• To advocate for enhanced safety measures to prevent future occurrences.

Main Methods:

• Review of reported cases of inadvertent intrathecal TXA administration.
• Analysis of the neurotoxic effects and mortality associated with this error.
• Evaluation of existing drug safety alerts and recommendations for improvement.

Main Results:

• A rising number of cases of accidental intrathecal TXA administration instead of local anesthetics for spinal anesthesia.
• Profound neurotoxicity, including rapid-onset convulsions, leading to a 50% mortality rate.
• Current safety alerts are insufficient to prevent these tragic errors.

Conclusions:

• Extensive dissemination of information and heightened awareness are necessary.
• Implementation of strict hospital protocols, including separate storage of TXA away from anesthetics and auxiliary labeling, is recommended.
• Large-scale safety strategies are essential to prevent drug-error mortality and preserve the life-saving benefits of TXA.